Clopidogrel versus ticagrelor in East Asian patients aged 75 years or older with acute coronary syndrome: observations from the GF-APT registry

Clopidogrel versus ticagrelor in East Asian patients aged 75 years or older with acute coronary syndrome: observations from the GF-APT registry

The benefits of potent antithrombotic therapy usually come at the expense of a higher risk of bleeding. The efficacy and safety of ticagrelor in elderly East Asian populations remains debated due to the concerns about the imbalance of ischemic and bleeding risks. This study aimed to compare the impa...

Full description

Bibliographic Details
Main Authors: Ziwei Xi, Zifeng Qiu, Jianan Li, Hong Qiu, Tingting Guo, Yong Wang, Jianfeng Zheng, Yanan Gao, Runlin Gao
Format: Article
Language:English
Published: Taylor & Francis Group 2022-11-01
Series:Platelets
Subjects:
acute coronary syndrome
antiplatelet therapy
clopidogrel
east asian
elderly
ticagrelor
Online Access:http://dx.doi.org/10.1080/09537104.2022.2118250

Internet

http://dx.doi.org/10.1080/09537104.2022.2118250

Similar Items